ORYX Legal Disclaimer
Terms and Conditions of Use of this Website
Thank you for visiting the ORYX website. ORYX maintains this website as a service to the internet community. Access to and use of information presented on the ORYX website is subject to the following terms and conditions, which may be revised at any time by ORYX. By using our website, you agree to be bound by the terms and conditions of use as amended from time to time. You may not access or use the website should you not want to be bound by these terms and conditions.
The ORYX website is designed to provide a general overview of ORYX and its development programs to a wide variety of audiences. The information contained in these pages is not intended to provide medical advice. ORYX’ drug candidates discussed in this website are presently being investigated in clinical trials and have not been approved for marketing by the Food and Drug Administration (FDA), the European Agency for the Evaluation of Medicinal Products (EMA), Federal Institute for Drugs and Medical Devices (BfArM), Paul Ehrlich Institut (PEI), or other national or foreign regulatory agencies.
All materials posted on the ORYX website are current as of the date posted. ORYX expressly disclaims any duty to update such information. This website contains forward-looking statements.
ALL INFORMATION ON THIS WEBSITE IS PROVIDED WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED. Although ORYX endeavors to ensure the accuracy of the information contained on its website, information on this website may contain technical inaccuracies, typographical mistakes or other errors. Therefore, you should verify the accuracy of all information if you intend to rely on it through independent sources. ORYX does not accept any liability for accuracy, completeness, reliability or relevance of the information offered on its website unless the mistake occurred intentionally. In addition, we are not liable for technical problems and do not warrant that our website is free from computer viruses. ORYX, its officers, directors and employees, affiliates and legal successors shall not be liable to you for any damages caused by your access to this website or your use of any information provided, including any kind of information which is incomplete or incorrect. Parts of the pages or the complete publication including all offers and information might be extended, changed or partly or completely deleted by ORYX without separate announcement. All offers are non-binding and without obligation.
ORYX does not want to receive confidential or proprietary information from you through its website. Therefore, please note that any communication or information transmitted to ORYX via the ORYX website is not confidential. By sending ORYX any information or material via the ORYX website you agree that ORYX may use such communication or material for any purpose whatsoever, including reproduction, publication and posting.
Copyright and Trademarks
It is the policy of ORYX to enforce its intellectual property rights to the fullest extent permitted under law. The entire content of the ORYX website, including any images or text, is copyrighted and may not be reproduced, distributed, downloaded, modified, reused, reposted or otherwise used except as provided herein (e.g. permitted downloads) without the express prior written permission of ORYX.
Referrals and Links
This website may provide links to other internet sites for the convenience of users. Such linked websites are not part of our website and we do not control the contents of third party websites. ORYX is not responsible for the availability or content of these external sites, nor does ORYX endorse, warrant or guarantee the information, products or services described or offered at these other internet sites.
This website is operated and maintained by ORYX. Any claims associated with this website or its use and these terms and conditions are governed exclusively by the laws of the Federal Republic of Germany.
This general disclaimer is part of the information offered on the ORYX website. If any of the terms and conditions should be determined invalid, then the remaining terms and conditions shall remain in full effect.